本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Recursion Pharmaceuticals, Inc.

5.32
-0.5900-9.98%
盤後5.13-0.1894-3.56%19:59 EDT
成交量:6,053.03萬
成交額:3.41億
市值:23.10億
市盈率:-2.95
高:6.20
開:6.04
低:5.30
收:5.91
52周最高:12.36
52周最低:3.79
股本:4.34億
流通股本:4.15億
量比:1.15
換手率:14.59%
股息:- -
股息率:- -
每股收益(TTM):-1.8042
每股收益(LYR):-1.6909
淨資產收益率:-86.34%
總資產收益率:-39.08%
市淨率:2.51
市盈率(LYR):-3.15

資料載入中...

2024/04/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/29

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/12

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/07

重要事件披露

Form 8-K - Current report